10% Stockholder Files Intent to Sell $34 Million in Arteris Stock
AIP has more than doubled off its 52-week low of $8.42.
Summary
A 10% stockholder, Bayview Legacy, plans to sell $34 million worth of Arteris stock, continuing a trend of insider distribution.
Key Events · Ownership and Investor Activity · AIP
-
Proposed Stock Sale
Bayview Legacy, a 10% stockholder, intends to sell 700,000 shares of common stock, valued at approximately $34.01 million.
-
Significant Stake Reduction
The proposed sale represents about 1.68% of the company's current market capitalization, indicating a substantial reduction in holdings by a major investor.
-
Ongoing Selling Pattern
This filing follows previous sales by Bayview Legacy, LLC, which sold 210,000 shares for $5.96 million over the past three months under a 10b5-1 plan.
Analysis · AIP · Manufacturing
Bayview Legacy, a 10% stockholder, has filed a Form 144 indicating its intent to sell 700,000 shares of Arteris common stock, valued at approximately $34 million. This proposed sale represents a significant disposition by a major investor and follows a pattern of smaller sales by the same entity over the past three months, suggesting a continued reduction in their stake.
How filings like this one have moved
In the 30 days to Oct 3, 2026, 29% of the 1653 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.58%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AIP was trading at $43.51 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $2B. The 52-week trading range was $8.42 to $50.26. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.